van der Wel Hanke, Ercan Altan, West Christopher M
Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.
J Biol Chem. 2005 Apr 15;280(15):14645-55. doi: 10.1074/jbc.M500600200. Epub 2005 Feb 10.
Skp1 is a cytoplasmic and nuclear protein of eukaryotes best known as an adaptor in SCF ubiquitin-protein isopeptide ligases. In Dictyostelium, Skp1 is subject to 4-hydroxylation at Pro(143) and subsequent O-glycosylation by alpha-linked GlcNAc and other sugars. Soluble cytosolic extracts have Skp1 prolyl 4-hydroxylase (P4H) activity, which can be measured based on hydroxylation-dependent transfer of [(3)H]GlcNAc to recombinant Skp1 by recombinant (Skp1-protein)-hydroxyproline alpha-N-acetyl-d-glucosaminyltransferase. The Dictyostelium Skp1 P4H gene (phyA) was predicted using a bioinformatics approach, and the expected enzyme activity was confirmed by expression of phyA cDNA in Escherichia coli. The purified recombinant enzyme (P4H1) was dependent on physiological concentrations of O(2), alpha-ketoglutarate, and ascorbate and was inhibited by CoCl(2), 3,4-dihydroxybenzoate, and 3,4-dihydroxyphenyl acetate, as observed for known animal cytoplasmic P4Hs of the hypoxia-inducible factor-alpha (HIFalpha) class. Overexpression of phyA cDNA in Dictyostelium yielded increased enzyme activity in a soluble cytosolic extract. Disruption of the phyA locus by homologous recombination resulted in loss of detectable activity in extracts and blocked hydroxylation-dependent glycosylation of Skp1 based on molecular weight analysis by SDS-PAGE, demonstrating a requirement for P4H1 in vivo. The sequence and functional similarities of P4H1 to animal HIFalpha-type P4Hs suggest that hydroxylation of Skp1 may, like that of animal HIFalpha, be regulated by availability of O(2), alpha-ketoglutarate, and ascorbate, which might exert novel control over Skp1 glycosylation.
Skp1是真核生物的一种胞质和核蛋白,作为SCF泛素-蛋白异肽连接酶中的衔接蛋白最为人所知。在盘基网柄菌中,Skp1在Pro(143)位点发生4-羟基化,随后被α-连接的GlcNAc和其他糖类进行O-糖基化。可溶性胞质提取物具有Skp1脯氨酰4-羟化酶(P4H)活性,可通过重组(Skp1-蛋白)-羟脯氨酸α-N-乙酰-d-葡糖胺基转移酶基于[(3)H]GlcNAc向重组Skp1的羟基化依赖性转移来测定。利用生物信息学方法预测了盘基网柄菌Skp1 P4H基因(phyA),并通过phyA cDNA在大肠杆菌中的表达证实了预期的酶活性。纯化的重组酶(P4H1)依赖于生理浓度的O(2)、α-酮戊二酸和抗坏血酸盐,并受到CoCl(2)、3,4-二羟基苯甲酸和3,4-二羟基苯乙酸的抑制,这与缺氧诱导因子-α(HIFα)类已知的动物胞质P4H的情况一致。phyA cDNA在盘基网柄菌中的过表达导致可溶性胞质提取物中的酶活性增加。通过同源重组破坏phyA基因座导致提取物中可检测活性丧失,并基于SDS-PAGE的分子量分析阻断了Skp1的羟基化依赖性糖基化,表明体内需要P4H1。P4H1与动物HIFα型P4H的序列和功能相似性表明,Skp1的羟基化可能与动物HIFα一样,受O(2)、α-酮戊二酸和抗坏血酸盐可用性的调节,这可能对Skp1糖基化施加新的控制。